FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) Forecast, Price Target & Analyst Ratings

NASDAQ:FBIOP • US34960Q2084

Current stock price

13.7099 USD
+0.02 (+0.15%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP).

Forecast Snapshot

Consensus Price Target

Price Target
$42.99
+ 213.54% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 24, 2026
Period
Q4 / 2025
EPS Estimate
$0.11
Revenue Estimate
26.693M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$42.99
Upside
+ 213.54%
From current price of $13.71 to mean target of $42.99, Based on 8 analyst forecasts
Low
$17.82
Median
$42.99
High
$69.98

Price Target Revisions

1 Month
1.39%
3 Months
50.78%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for FBIOP. The average price target is 42.99 USD. This implies a price increase of 213.54% is expected in the next year compared to the current price of 13.7099.
The average price target has been revised upward by 50.78% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FBIOP Current Analyst RatingFBIOP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

FBIOP Historical Analyst RatingsFBIOP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
FBIOP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FBIOP.
In the previous month the buy percentage consensus was at a similar level.
FBIOP was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 24, 2026
Period
Q4 / 2025
EPS Estimate
$0.11
Revenue Estimate
26.693M
Revenue Q2Q
76.54%
EPS Q2Q
114.96%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
13.07%
EPS (1 Month)
0.00%
EPS (3 Months)
131.88%

Next Earnings Summary

FBIOP is expected to report earnings on 3/24/2026. The consensus EPS estimate for the next earnings is 0.11 USD and the consensus revenue estimate is 26.69M USD.
The next earnings revenue estimate has been revised upward by 13.07% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
FBIOP revenue by date.FBIOP revenue by date.
75.74M
10.10%		84.513M
11.58%		57.675M
-31.76%		74.808M
29.71%		111.72M
49.34%		148.21M
32.66%		680.14M
358.90%		721.75M
6.12%		736.44M
2.04%
EBITDA
YoY % growth
FBIOP ebitda by date.FBIOP ebitda by date.
-196.17M
-12.81%		-133.245M
32.08%		-106.776M
19.86%		-54.774M
48.70%		-34.17M
37.62%		-12.342M
63.88%		N/AN/AN/A
EBIT
YoY % growth
FBIOP ebit by date.FBIOP ebit by date.
-203.56M
-13.72%		-139.242M
31.60%		-111.24M
20.11%		-65.051M
41.52%		-28.18M
56.68%		-12.342M
56.20%		180.74M
1,564.43%		195.84M
8.35%		188.5M
-3.75%
Operating Margin
FBIOP operating margin by date.FBIOP operating margin by date.
-268.76%-164.76%-192.87%-86.96%-25.22%-8.33%26.57%27.13%25.60%
EPS
YoY % growth
FBIOP eps by date.FBIOP eps by date.
-14.51
-5.15%		-8.97
38.18%		-3.27
63.55%		0.32
109.83%		0.01
-96.83%		1.54
15,000.00%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		0.11
114.96%
Revenue
Q2Q % growth		26.693M
76.54%
EBITDA
Q2Q % growth		8.874M
138.78%
EBIT
Q2Q % growth		-8.415M
69.23%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FBIOP Yearly Revenue VS EstimatesFBIOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
FBIOP Yearly EPS VS EstimatesFBIOP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
35.19%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
35.16%
Revenue Next 5 Year
64.44%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
23.67%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FORTRESS BIOTECH INC - FBIO 9 3/8 PERP / FBIOP Forecast FAQ

Can you provide the average price target for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP stock?

8 analysts have analysed FBIOP and the average price target is 42.99 USD. This implies a price increase of 213.54% is expected in the next year compared to the current price of 13.7099.

What is the next earnings date for FBIOP stock?

FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) will report earnings on 2026-03-24, after the market close.

What are the consensus estimates for FBIOP stock next earnings?

The consensus EPS estimate for the next earnings of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) is 0.11 USD and the consensus revenue estimate is 26.69M USD.

What is the expected long term growth rate for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP)?

The expected long term growth rate for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP) is 35.16%.